A carregar...

Tumour MLH1 promoter region methylation testing is an effective pre-screen for Lynch Syndrome (HNPCC)

BACKGROUND & AIMS: Lynch syndrome patients have DNA mismatch repair deficiency and up to 80% life-time risk of colorectal cancer. Screening of mutation carriers reduces colorectal cancer incidence and mortality. Selection for constitutional mutation testing relies on family history (Amsterdam an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Genet
Main Authors: Newton, K, Jorgensen, NM, Wallace, AJ, Buchanan, DD, Lalloo, F, McMahon, RFT, Hill, J, Evans, DG
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159427/
https://ncbi.nlm.nih.gov/pubmed/25280751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmedgenet-2014-102552
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!